loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha)? Find Controlled & Modified Release used in 19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) to address drug delivery challenges on PharmaCompass.

    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    View Presentation

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Menu

    19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha)

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7,465Xls

    Filters

    clear-filterReset all filters
    Client Email Product
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5Gangwal Healthcare

    02 2Aeon Procare

    03 20BASF

    04 1Huzhou Sunflower Pharmaceutical

    05 2Ideal Cures Pvt Ltd

    06 16Kerry

    07 1Kima Chemical

    08 1Lonza Capsugel

    09 2Novo Excipients

    10 1Sigachi Industries

    11 2The Dow Chemical Company

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    Gangwal Healthcare

    India
    arrow
    CPhI India 2024
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Dosage Form : Capsule, Tablet

    Grade : Oral

    Brand Name : DiCOM-DC® SR300

    Application : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

    Excipient Details : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

    Pharmacopoeia Ref : In-house

    Technical Specs : NA

    Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

    Dosage Form : Capsule, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc

    Dosage Form : Capsule, Tablet

    Category : Co-Processed Excipients, Controlled & Modified Release, Direct Compression

    Brand : DICOM-DC® SR300

    Applications : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.

    Pharmacopoeia Ref : In-house

    Technical Specs : NA

    Grade : Oral

    arrow
    Gangwal Healthcare DiCOM-DC® SR300

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    02

    Gangwal Healthcare

    India
    arrow
    CPhI India 2024
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Dosage Form : Capsule, Granule / Pellet, Tablet

    Grade : Oral

    Brand Name : Gellets-P®

    Application : Controlled & Modified Release

    Excipient Details : Gellets-P are Microcrystalline Cellulose based spheres for the manufacturing of pellets and modified release products.

    Pharmacopoeia Ref : In-house

    Technical Specs : NA

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Capsule, Granule / Pellet, Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Ingredient(s) : Microcrystalline Cellulose

    Dosage Form : Capsule, Granule / Pellet, Tablet

    Category : Controlled & Modified Release

    Brand : GELLETS-P®

    Applications : Gellets-P are Microcrystalline Cellulose based spheres for the manufacturing of pellets and modified release products.

    Pharmacopoeia Ref : In-house

    Technical Specs : NA

    Grade : Oral

    arrow
    Gangwal Healthcare Gellets-P®

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    03

    Kerry

    SHEFFCEL

    arrow
    AAPS 2024
    Not Confirmed

    04

    BASF

    KOLLIDON SR

    arrow
    AAPS 2024
    Not Confirmed

    BASF

    Germany
    arrow
    AAPS 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Tablet, Topical Film, Transdermal Patch

    Grade :

    Brand Name : Kollidon SR

    Application : Controlled & Modified Release, Direct Compression, Granulation

    Excipient Details : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

    Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 %...

    Technical Specs :

    Ingredient(s) : Hydrated Silica, Lauryl Sulfate, Polyvinyl Acetate, Povidone

    Dosage Form : Capsule, Tablet, Topical Film, Transdermal Patch

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Hydrated Silica, Lauryl Sulfate, Polyvinyl Acetate, Povidone

    Dosage Form : Capsule, Tablet, Topical Film, Transdermal Patch

    Category : Controlled & Modified Release, Direct Compression, Granulation

    Brand : KOLLIDON SR

    Applications : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

    Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    05

    Aeon Procare

    TALC

    arrow
    AAPS 2024
    Not Confirmed

    06

    Kerry

    SHEFFCEL CR

    arrow
    AAPS 2024
    Not Confirmed

    07

    Huzhou Sunflower Pharmaceutical

    COPOVIDONE

    arrow
    AAPS 2024
    Not Confirmed

    Huzhou Sunflower Pharmaceutical

    China
    arrow
    AAPS 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet

    Grade : Oral

    Brand Name : Copovidone

    Application : Controlled & Modified Release, Fillers, Diluents & Binders, Film Formers & Plasticizers, Solubilizers, Taste Masking

    Excipient Details : Copovidone is used as a tablet binder, a film-former, & as part of the matrix material used in controlled-release formulations. It can be used as a binder for direct compression & wet granulation.

    Pharmacopoeia Ref :

    Technical Specs :

    Ingredient(s) : Copovidone K25-31

    Dosage Form : Tablet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Copovidone K25-31

    Dosage Form : Tablet

    Category : Controlled & Modified Release, Fillers, Diluents & Binders, Film Formers & Plasticizers, Solubilizers, Taste Masking

    Brand : COPOVIDONE

    Applications : Copovidone is used as a tablet binder, a film-former, & as part of the matrix material used in controlled-release formulations. It can be used as a binder for direct compression & wet granulation.

    Pharmacopoeia Ref : Not Available

    Technical Specs : Not Available

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    08

    Novo Excipients

    COPOVIDONE

    arrow
    AAPS 2024
    Not Confirmed

    09

    Ideal Cures Pvt Ltd

    ESPHERES EM

    arrow
    AAPS 2024
    Not Confirmed

    10

    Ideal Cures Pvt Ltd

    INSTAMODEL BLEND

    arrow
    AAPS 2024
    Not Confirmed

    11

    Sigachi Industries

    HICEL MCC SPHERES

    arrow
    AAPS 2024
    Not Confirmed

    12

    Kerry

    SHEFFCOAT™ S

    arrow
    AAPS 2024
    Not Confirmed

    13

    The Dow Chemical Company

    METHOCEL™

    arrow
    AAPS 2024
    Not Confirmed

    The Dow Chemical Company

    U.S.A
    arrow
    AAPS 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Tablet, Capsule

    Grade :

    Brand Name : METHOCEL™

    Application : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules

    Excipient Details : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

    Pharmacopoeia Ref :

    Technical Specs :

    Ingredient(s) : Hydroxypropyl Methylcellulose

    Dosage Form : Tablet, Capsule

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Hydroxypropyl Methylcellulose

    Dosage Form : Tablet, Capsule

    Category : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules

    Brand : METHOCEL™

    Applications : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

    Pharmacopoeia Ref : Not Available

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    14

    Kerry

    SHEFFCOAT™ENHANCE

    arrow
    AAPS 2024
    Not Confirmed

    15

    Kima Chemical

    HYDROXYPROPYL METHYL CELLULOSE (75K100)

    arrow
    AAPS 2024
    Not Confirmed

    16

    Kerry

    SHEFFCOAT™ GLIDE

    arrow
    AAPS 2024
    Not Confirmed

    17

    Kerry

    SHEFFCOAT™ L

    arrow
    AAPS 2024
    Not Confirmed

    18

    Kerry

    SHEFFCOAT™ PVA

    arrow
    AAPS 2024
    Not Confirmed

    19

    Kerry

    SHEFFCOAT™

    arrow
    AAPS 2024
    Not Confirmed

    20

    Lonza Capsugel

    VCAPS® ENTERIC

    arrow
    AAPS 2024
    Not Confirmed

    Lonza Capsugel

    U.S.A
    arrow
    AAPS 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule

    Grade : Oral

    Brand Name : Vcaps® Enteric

    Application : Controlled & Modified Release, Vegetarian Capsules

    Excipient Details : It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.

    Pharmacopoeia Ref : Complies with relevant Europea...

    Technical Specs : Water content – less than 6%; Size #0

    Ingredient(s) : HPMC AS, Hydroxypropyl Methyl Cellulose

    Dosage Form : Capsule

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : HPMC AS, Hydroxypropyl Methyl Cellulose

    Dosage Form : Capsule

    Category : Controlled & Modified Release, Vegetarian Capsules

    Brand : VCAPS® ENTERIC

    Applications : It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.

    Pharmacopoeia Ref : Complies with relevant European, Japanese and US Pharmacopeia monographs

    Technical Specs : Water content – less than 6%; Size #0

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    21

    Kerry

    SHEFFCOAT™ CG

    arrow
    AAPS 2024
    Not Confirmed

    22

    Kerry

    SHEFFCOAT™ D

    arrow
    AAPS 2024
    Not Confirmed

    23

    Kerry

    SHEFFCOAT™ EC

    arrow
    AAPS 2024
    Not Confirmed

    24

    Kerry

    SHEFF COAT™ PVA+

    arrow
    AAPS 2024
    Not Confirmed

    25

    Kerry

    SHEFFCOAT™ HS

    arrow
    AAPS 2024
    Not Confirmed

    26

    Kerry

    SHEFFCOAT™ MP

    arrow
    AAPS 2024
    Not Confirmed

    27

    BASF

    KOLLICOAT SR 30 D

    arrow
    AAPS 2024
    Not Confirmed

    BASF

    Germany
    arrow
    AAPS 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet, Topical Film

    Grade :

    Brand Name : Kollicoat SR 30 D

    Application : Coating Systems & Additives, Controlled & Modified Release, Taste Masking

    Excipient Details : pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

    Pharmacopoeia Ref : Ph. Eur.: Poly(vinyl acetate) ...

    Technical Specs :

    Ingredient(s) : Polyvinyl Acetate, Sodium Lauryl Sulfate

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet, Topical Film

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Polyvinyl Acetate, Sodium Lauryl Sulfate

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet, Topical Film

    Category : Coating Systems & Additives, Controlled & Modified Release, Taste Masking

    Brand : KOLLICOAT SR 30 D

    Applications : pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

    Pharmacopoeia Ref : Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    28

    BASF

    KOLLIDON 25

    arrow
    AAPS 2024
    Not Confirmed

    29

    BASF

    KOLLIDON 30

    arrow
    AAPS 2024
    Not Confirmed

    30

    BASF

    KOLLICOAT PROTECT

    arrow
    AAPS 2024
    Not Confirmed

    BASF

    Germany
    arrow
    AAPS 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet

    Grade :

    Brand Name : Kollicoat Protect

    Application : Coating Systems & Additives, Controlled & Modified Release

    Excipient Details : Flexible water soluble instant release coating polymer, especially used for moisture protection

    Pharmacopoeia Ref : Excipient based on Kollicoat®...

    Technical Specs :

    Ingredient(s) : Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer, Polyvinyl Alcohol

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer, Polyvinyl Alcohol

    Dosage Form : Capsule, Granule / Pellet, Softgel Capsule, Tablet

    Category : Coating Systems & Additives, Controlled & Modified Release

    Brand : KOLLICOAT PROTECT

    Applications : Flexible water soluble instant release coating polymer, especially used for moisture protection

    Pharmacopoeia Ref : Excipient based on Kollicoat® IR and monographed raw materials

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth